Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

Alzheimer Disease Clinical Trial

— MemScreen  

Official title:

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03811184
• Other study ID #: 2018-A02672-53
• Status: Recruiting
• Start date: January 17, 2019
• Est. completion date: June 2020

Study information

• Verified date: January 2019
• Source: MemScreen
• Contact: Julien Dumurgier, MD
• Phone: 0033140054313
• Email: julien.dumurgier[@]aphp.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions.

The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests.

The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen.

The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

Description:

Characteristics of MemScreen :

• Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder.

• The application is a self-test by the patient under the supervision of a doctor.

• The doctor has an account to be able to pass the test to patients.

• The tablet test is anonymous without the possibility to identify the patient.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: June 2020
• Est. primary completion date: March 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Major patients followed in memory clinic.

• Performing a neuropsychological assessment less than 6 months old.

• No visual or motor deficiency impeding the use of a digital tablet.

Exclusion Criteria:

• None.

Related Conditions & MeSH terms

• Alzheimer Disease
• Cognitive Dysfunction
• Cognitive Impairment

Intervention

Diagnostic Test:
• MemScreen
Neuropsychological test on smartphone or digital tablet, on self assesment.

Locations

Country	Name	City	State
France	Centre Neurologie Cognitive Hôpital Fernand Widal	Paris

Sponsors (1)

Lead Sponsor	Collaborator
MemScreen

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ability to detect patients with mild cognitive impairment.	To evaluate the ability of MemScreen to discriminate patients with an objective memory disorder from a validated neuropsychological reference test: the free and cued selective reminding test.	through study completion, an average of 6 months